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Abstract
Thirty seven cases of oesophageal
squamous cell carcinoma were studied
by applying DNA slot blot analysis and
in situ hybridisation using type specific
probes for HPV 6, 11, 16 and 18. Cases of
condyloma accuminata, cervical carcin-
oma, and laryngeal papilloma were used
as controls. Blocks including areas of
invasive carcinoma, intraepithelial
neoplasia, and normal epithelium were
studied in each case. No HPV genome
was detectable in any of the oesophageal
cases. It is concluded that these types of
HPV do not have an association with
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Human papillomavirus (HPV) infection is
associated with the development of papillomas
or condylomas in various parts of the body,l1
and HPV types 6 and 11 are most frequently
found in such benign lesions.5 HPV infection
has also been confirmed in oesophageal
papillomas by the presence of koilocytic
features,6 viral antigen,7 or viral genome.'
There is also a suggestion that HPV infection
of the oesophagus is on the increase.9
The recent detection of the HPV genome in
cervical squamous cell carcinoma has promp-
ted the search for virus in squamous cell
carcinomas (SCC) in other sites of the body.
HPV types 16 and 18 are most frequently
detected in these malignant lesions and their
association with malignancy seems to be
relatively independent of site.34 While there
are a few reports suggesting that HPV is
detectable in oesophageal SCC,11-14 this has
not been confirmed in other studies.4
To investigate this possibility further we
applied in situ hybridisation and DNA slot-
blot analysis to a series of oesophageal
SCC occurring in Hong Kong. The former
technique proved sufficiently sensitive to
detect HPV in cervical SCC'5 where tumour
cells are likely to contain many copies of viral
genome. DNA slot-blot analysis, however,
can detect virus where the genomic copies are
low.
Methods
Thirty seven cases of oesophageal SCC where
total oesophagectomy had been performed
were selected for study. These included a
selection of 14 cases with multiple separate
primary tumours in the oesophagus. The whole
specimen in each case had been totally
embedded for histological examination to
define the extent of invasive tumour and
intraepithelial neoplasm. DNA was extracted
from the tumour in 21 of these cases before
wax embedding. For each case, blocks
representative of invasive tumour, intra-
epithelial tumour, and normal adjacent
epithelium were selected for analysis by in situ
hybridisation.
Cases of condyloma accuminata and laryn-
geal papillomata containing HPV 6 or 11 and
cervical SCC containing HPV 16 or 18 were
chosen as positive control tissues. The human
cell lines CaSki and SiHa, both containing
HPV 16 genome, and HeLa, containing HPV
18, were also used as positive controls forDNA
slot-blot analysis. All three cell lines were
obtained from American Tissue Type Culture
Collection, USA.
Plasmids containing HPV types 6, 11, 16 and
18DNA were kindly provided by Professor zur
Hausen and Dr Gissmann (German Cancer
Research Centre, Heidelberg, Federal
Republic of Germany).""'9 HPV probes were
obtained by digesting the plasmid DNA with
BamH I for HPV 6, 11, 16, and EcoR I for
HPV 18. The viral DNAs were labelled with
digoxigenin for in situ hybridisation using a
detection kit (Boehringer, Mannheim GmbH,
Pensberg, West Germany), or oligo-labelled
for slot blot hybridisation according to the
supplier's instructions (Bresatec, Australia).
IN SITU HYBRIDISATION
The method used was a modification of the
one previously described.20 Hybridisation was
performed with digoxigenin-labelled probes at
a final concentration of 200 ng/ml in 50%
(v/v) deionised formamide, 10% (w/v) dextran
sulphate, 2 x SSC (30 mM sodium chloride, 3
mM sodium citrate) and 0-2% dried milk
powder at 42°C overnight.
Post-hybridisation wash included 2 x SSC
at 60°C for 10 minutes, followed by 0-2 x SSC
at 42°C for 10 minutes with stirring. For
sections to be washed in low stringency, the
initial temperature for washing was reduced to
450C.
Signal detection was performed using poly
sheep anti-digoxigenin-Fab fragments con-
jugated to alkaline phosphatase (Boehringer,
Mannhein, Biochema, Penzeberg, West
Germany) according to the supplier's
recommendations.
SLOT-BLOT ANALYSIS21 22
DNA (5 ,ug) extracted from cryosections using
proteinase K was blotted on to a nylon
membrane (Genescreen Plus, Dupont, NEN
Products, Boston, Massachusetts) according to
the supplier's instructions.
The membranes were hybridised to the
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Figure 1 (A) Papilloma
of larynx with strong












denatured 32p-oligo-labelled HPV DNA probe
(0-5-2 ng/ml) in 50% formamide, 1 M NaCl,
10% dextran sulphate, 1% sodium dodecyl
sulphate, 0 2% polyvinyl-pyrrolidone, 0-2%
Ficoll, 0-2% bovine serum albumin, 50 mM
TRIS-HCI (pH 7 5), 0 1% sodium pyro-
phosphate (NaPPi) and denatured salmon
sperm DNA at 42°C for 40 hours. The final
wash of the membranes was in solution
containing 0-2 x SSC, 0-1% NaPPi, 0-1 mM
EDTA and 1% sodium dodecyl sulphate at
65°C for 40 minutes.
Autoradiography was carried out using an
X-OMAT AR X-ray film (Kodak).
Results
IN SITU HYBRIDISATION
With post-hybridisation washing in high
stringency, strong signal was detectable in the
control tissues for each HPV type. Similar
washing conditions gave no detectable signal in
the cases tested. A representative pair of
control condyloma and oesophageal SCC
hybridised with HPV 11 probe is shown in
fig 1. When washing was performed in low
stringency, there was still no signal in all of the
cases tested and the background was the same
between the sections hybridised to the HPV
probes and the plasmid without the viral
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Figure 2 No signal was detected in DNA slot-blot using 5 g total DNA from each of the 21 cases of invasive carcinoma (A, 1-6; B, 1-6; C, 1-6
and D, 1-3):
(A) Hybridisation with HPV16, with pg, 100 ng, ng, ng, 100 pg and lOpg DNA from CaSki cell line (E, 1-6) as control.
(B) Hybridisation with HPV18, with pg, 100 ng, 10ng, ng, 100 pg and lOpg ofDNAfrom HeLa cell line (E, 1-6) as control.
(C) Hybridisation with HPV6, with 10 pg DNA from CaSki (E, 1), SiHa (E, 2), HeLa (E, 3) and laryngeal papilloma (E, 4) as controls.
(D) Hybridisation with HPVII, with 10 pg DNA from CaSki (E, 1), SiHa (E, 2), HeLa (E, 3) and laryngeal papilloma (E, 4) as controls.
inserts. Similar negativity was noted for the
invasive carcinomas, intraepithelial neoplasia,
and normal mucosa. This indicated that there
were no focal collections of cells containing
abundant virons of these HPV types.
DNA SLOT-BLOT ANALYSIS
By titrating the DNA extracted from cell lines,
we determined our sensitivity in HPV detec-
tion. HPV 16 genome was detectable in l0 ng of
totalDNA from CaSki cell lines but not in 5 pg
of total DNA from each of the cases when
hybridised in the same conditions (fig 2A). As
there was an average of400-500 copies ofHPV
16 per cell in CaSki cell lines, our DNA slot-
blot should be able to detect HPV 16 genome
with a sensitivity of up to an average of one
copy per cell. This was further supported by
our ability to detect the genome in 2 yg of total
DNA from the SiHa cell line which contained
one to two copies per cell. Similarly, HPV 18
genome was detectable in 1 Mg of total DNA
from HeLa cell lines but not in 5 Mg total DNA
from SCC (fig 2B). As HeLa cell lines contained
four to 50 copies of viral genome per cell, we
should have been able to detect HPV 18
genome with a sensitivity ofup to 08-10 copies
per cell in SCC.
HPV 6 or 11 genome was readily detectable
in 5 Mg of total DNA from the cervical
condylomata and laryngeal papillomata, but
not in a similar amount of total DNA from the
oesophageal SCC. As the copy numbers ofviral
genome in the condylomata and papillomata
were unknown, the sensitivity for detection of
HPV 6 and 11 was not determined (fig 2C, D).
Our inability to detect any HPV genome ofany
type in the 21 cases studied indicated that either
these HPV types were not present in the
invasive tumours, or that, there were too few
copies of the viral genome.
Discussion
SCC, the most common malignancy of the
oesophagus,23 is common among Southern
Chinese, and ranks fifth in the league table of
deaths from cancer in Hong Kong.24 The recent
interest in HPV and its association with
cervical SCC has led to the investigation of its
possible aetiological role at other sites of the
body. As in cervical SCC, detection of viral
genome has been reported in several other
mucosal sites."~
Hille et al reported detection ofHPV antigen
by immunostaining oesophageal SCC in South
African patients in about a third of the cases.'2
HPV genome has been detected in three cases
of oesophageal SCC in Australian patients by
Kulski et al using filter in situ hybridisation
with a probe mixture containing HPV ty'pes 1 1,
13, 16 and 18." These workers found no
detectable viral antigen in these cases, suggest-
ing that detection of the genome is more
sensitive than immunostaining.
By contrast, Kiyabu et al were unable to
detect HPV 16 or 18 in invasive SCC of the
oesophagus in North American patients using
the polymerase chain reaction.4 The possible
role of other types of the virus was not
investigated, and no mention was made of
intraepithelial neoplasia or areas of adjacent
normal epithelium.
Our inability to detect the presence ofHPV
in cases ofSCC of the oesophagus is in keeping
with the findings of Kiyabu et al.4 Moreover,
by performing in situ hybridisation, we can
correlate histology with viral genome detec-
tion. As no HPV was detectable in intra-
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epithelial neoplasia and normal epithelium in
these cases, it seems that virus is absent even at
earlier stages of the disease process. The
absence ofHPV 6 and 11 also suggests that the
pathogeneses of papilloma and SCC of the
oesophagus are completely different.
Our findings are consistent with the view
that HPV is neither necessary nor sufficient for
the development of oesophageal SCC. This is
in keeping with previous epidemiological
findings. Firstly, unlike SCC of the cervix,
papillomata are rare in the oesophagus, and in
vitro experiments suggest that oesophageal
tissues are less prone to mutation by HPV than
cervical or laryngeal tissues.25 Secondly, areas
with a high incidence of oesophageal SCC do
not necessarily have a particularly high
prevalence of HPV infection. Preliminary
results in Hong Kong suggest that HPV infec-
tion of the female genital tract is low relative to
that of most Western countries (Collins RJ,
Ngan HYS, Hsu C, et al. Abstract presented at
the thirty fourth annual scientific meeting of
the Royal College of Pathologists of Australia,
1989), and yet we have a high incidence of
cervical SCC. Thirdly, other environmental
factors such as diet or exposure to chemical
carcinogens are epidemiologically related to
SCC of the oesophagus. It is, however, still
possible for HPV to act as an additional
promotor after tumour induction by these
carcinogens.
In conclusion, we were unable to detect HPV
genome in oesophageal SCC in Hong Kong
using techniques that could detect small copy
number of virons in tumour cells. This strongly
suggests that HPV does not have a similar role
in SCC of the oesophagus as is the case in
comparable malignancies of other mucosal
sites.
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